Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
Br. J. Haematol., Jul;158(1):120-8 (2012)
National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-s
Biol. Blood Marrow Transplant., Mar;18(3):334-47 (2012)
NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
Biol. Blood Marrow Transplant., Dec;17(12):1725-38 (2011)
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
Biol. Blood Marrow Transplant., Oct;17(10):1424-7 (2011)
Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.
Biol. Blood Marrow Transplant., Jan;18(1):84-91 (2012)
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.
Blood., Aug;118(5):1421-8 (2011)
A simulation-based comparison of two methods for determining relaxation rates from relaxometry images.
Magn Reson Imaging., May;29(4):497-506 (2011)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Blood., Mar;117(11):3214-9 (2011)
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., Sep;17(9):1308-15 (2011)
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
J. Clin. Oncol., Jan;29(2):214-22 (2011)
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
Biol. Blood Marrow Transplant., May;17(5):723-8 (2011)
Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.
Biol. Blood Marrow Transplant., Dec;16(12):1674-81 (2010)
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biol. Blood Marrow Transplant., Mar;17(3):341-50 (2011)
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
J. Clin. Oncol., Feb;28(6):1011-6 (2010)
Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., Apr;16(4):515-24 (2010)
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.
Biol. Blood Marrow Transplant., Feb;16(2):263-72 (2010)
Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
Biol. Blood Marrow Transplant., Feb;16(2):223-30 (2010)
BK nephropathy in pediatric hematopoietic stem cell transplant recipients.
Pediatr Transplant., Nov;13(7):913-8 (2009)
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
Biol. Blood Marrow Transplant., Dec;14(12):1380-4 (2008)
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
Blood., Jan;113(2):306-8 (2009)